Buy Tirzepatide 100mg: Dual GIP/GLP-1 Agonist for Advanced Metabolic Research

Tirzepatide (100mg) is a high-capacity dual GIP and GLP-1 receptor agonist designed for advanced laboratory and bulk research use. This large 100mg vial supports extended studies, high-dose protocols, and bulk reconstitution in metabolic research. Tirzepatide is widely studied for its potent effects on type 2 diabetes, obesity, insulin sensitivity, appetite regulation, significant weight loss, and cardiovascular benefits.

Molecular Formula: C225H348N48O68 Molecular Weight: 4813.527 g/mol Purity: ≥99% (lyophilized, research-grade)

Important Notice: This peptide is strictly intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Please review and agree to our Terms and Conditions before ordering.

What is Tirzepatide?

Tirzepatide is a synthetic polypeptide that acts as a dual agonist at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism provides superior effects on glucose control and body weight reduction compared to single-agonist therapies.

The 100mg vial is ideal for researchers requiring larger quantities for long-term studies, dose-response experiments, stability testing, or bulk reconstitution protocols.

Mechanism of Action in Research

Tirzepatide works by:

• Stimulating glucose-dependent insulin secretion
• Suppressing glucagon release
• Slowing gastric emptying
• Reducing appetite and caloric intake via central nervous system effects
• Improving insulin sensitivity and lipid metabolism

This combined GIP/GLP-1 activation leads to enhanced glycemic control and substantial fat mass reduction in experimental models.

Key Research Findings and Benefits

Glycemic Control in Type 2 Diabetes

Studies show significant HbA1c reductions (up to -2.3% to -2.46%) and improved insulin sensitivity at higher doses.

Weight Loss and Obesity Research

Tirzepatide has demonstrated average weight reductions of up to ~21% in obesity models over extended periods, with strong effects on visceral fat loss.

Cardiovascular and Metabolic Support

Research indicates favorable changes in blood pressure, lipid profiles, and potential cardiometabolic risk reduction.

Research Applications

The 100mg vial is especially valuable for:

• Long-term and high-dose metabolic studies
• Bulk reconstitution and stability testing
• Obesity and type 2 diabetes animal models
• Comparative dual-agonist research
• Dose-response and chronic administration experiments

Why Choose 99% Pure Tirzepatide 100mg?

Our Tirzepatide 100mg offers ≥99% purity for reliable, reproducible results in receptor binding, insulin dynamics, and long-term metabolic outcome studies. Third-party tested and lyophilized for maximum stability.

In summary, Tirzepatide 100mg is a high-capacity dual GIP/GLP-1 agonist peptide for advanced research into type 2 diabetes, obesity, weight loss, insulin sensitivity, and cardiometabolic health. Scale up your metabolic studies with this premium research tool.